Hua Xu

Prof. Dr. Hua Xu

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2012 in Molecular Brain
Verified
Journal Article
Open access
PDF file
JYJia-Le Yang
Jia-Le Yang
BXBo Xu
Bo Xu
SLShuang-Shuang Li
Shuang-Shuang Li
WZWei-Shi Zhang
Wei-Shi Zhang
HXHua Xu
Hua Xu
YZYu-Qiu Zhang
Yu-Qiu Zhang
Background: Spinal glia, particularly microglia and astrocytes, are of the utmost importance in the development and maintenance of chronic pain. A recent study from our laboratory revealed that gabapentin, a recommended first-line treatment for multiple neuropathic conditions, could also efficiently antagonize thermal hyperalgesia evoked by complete Freund's adjuvant (CFA)-induced monoarthritis (MA). In the present study, we investigated whether the spinal glia are involved in the anti-hyperalgesic effect of gabapentin and how this event occurs.Results: Unilateral intra-articular injection of CFA produced a robust activation of microglia and astrocytes. These cells exhibited large cell bodies, thick processes and increases in the ionized calcium binding adapter molecule 1 (Iba-1, a microglial marker) or the glia fibrillary acidic protein (GFAP, an astrocytic marker). These cells also displayed immunoreactive signals, and an upregulation of the voltage-gated calcium channels (VGCCs) α2/δ-1 subunit, CX3CL1 and CX3CR1 expression levels in the spinal cord. These changes were associated with the development of thermal hyperalgesia. Immunofluorescence staining showed that VGCC α2/δ-1 subunit, a proposed gabapentin target of action, was widely distributed in primary afferent fibers terminals and dorsal horn neurons. CX3CL1, a potential trigger to activate microglia, colocalized with VGCC α2/δ-1 subunits in the spinal dorsal horn. However, its receptor CX3CR1 was mainly expressed in the spinal microglia. Multiple intraperitoneal (i.p.) gabapentin injections (100 mg/kg, once daily for 4 days with the first injection 60 min before intra-articular CFA) suppressed the activation of spinal microglia, downregulated spinal VGCC α2/δ-1 subunits decreased CX3CL1 levels and blocked the development of thermal hyperalgesia in MA rats.Conclusions: Here we provide the first evidence that gabapentin diminishes CX3CL1 signaling and spinal microglia activation induced by joint inflammation. We also show that the VGCC α2/δ-1 subunits might be involved in these events.

7 July 2010 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
BXBo Xu
Bo Xu
WZWei‐Shi Zhang
Wei‐Shi Zhang
JYJia‐ Le Yang
Jia‐ Le Yang
NLNing Lû
Ning Lû
XDXiao‐Ming Deng
Xiao‐Ming Deng
YZYu‐Qiu Zhang
Yu‐Qiu Zhang

20 March 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
HLHao-Ling Li
Hao-Ling Li
YHYan Huang
Yan Huang
YZYa-Lan Zhou
Ya-Lan Zhou
RTRun-Hua Teng
Run-Hua Teng
SZShu-Zhuan Zhou
Shu-Zhuan Zhou
YYYong-Xing Yao
Yong-Xing Yao
Neuropathic pain is among the most debilitating forms of chronic pain. Studies have suggested that chronic pain pathogenesis involves neuroimmune interactions and blood–spinal cord barrier (BSCB) disruption. However, the underlying mechanisms are poorly understood. We modeled neuropathic pain in rats by inducing chronic constriction injury (CCI) of the sciatic nerve and analyzed the effects on C-X-C motif chemokine 10 (CXCL10)/CXCR3 activation, BSCB permeability, and immune cell migration from the circulation into the spinal cord. We detected CXCR3 expression in spinal neurons and observed that CCI induced CXCL10/CXCR3 activation, BSCB disruption, and mechanical hyperalgesia. CCI-induced BSCB disruption enabled circulating T cells to migrate into the spinal parenchyma. Intrathecal administration of an anti-CXCL10 antibody not only attenuated CCI-induced hyperalgesia, but also reduced BSCB permeability, suggesting that CXCL10 acts as a key regulator of BSCB integrity. Moreover, T cell migration may play a critical role in the neuroimmune interactions involved in the pathogenesis of CCI-induced neuropathic pain. Our results highlight CXCL10 as a new potential drug target for the treatment of nerve injury–induced neuropathic pain.

3 March 2015 in Molecular Brain
Verified
Journal Article
Open access
PDF file
XGXiyao Gu
Xiyao Gu
BLBen-Long Liu
Ben-Long Liu
KZKai-Kai Zang
Kai-Kai Zang
YLYang Liu
Yang Liu
HXHua Xu
Hua Xu
YZYu-Qiu Zhang
Yu-Qiu Zhang
Systemically administered dexmedetomidine (DEX), a selective α2 adrenergic receptor (α2-AR) agonists, produces analgesia and sedation. Peripherally restricted α2-AR antagonist could block the analgesic effect of systemic DEX on neuropathic pain, with no effect on sedation, indicating peripheral analgesic effect of DEX. Tetrodotoxin-resistant (TTX-R) sodium channel Nav1.8 play important roles in the conduction of nociceptive sensation. Both α2-AR and Nav1.8 are found in small nociceptive DRG neurons. We, therefore, investigated the effects of DEX on the Nav1.8 currents in acutely dissociated small-diameter DRG neurons. Whole-cell patch-clamp recordings demonstrated that DEX concentration-dependently suppressed TTX-R Nav1.8 currents in small-diameter lumbar DRG neurons. DEX also shifted the steady-state inactivation curves of Nav1.8 in a hyperpolarizing direction and increased the threshold of action potential and decrease electrical and chemical stimuli-evoked firings in small-diameter DRG neurons. The α2-AR antagonist yohimbine or α2A-AR antagonist BRL44408 but not α2B-AR antagonist imiloxan blocked the inhibition of Nav1.8 currents by DEX. Immunohistochemistry results showed that Nav1.8 was predominantly expressed in peripherin-positive small-diameter DRG neurons, and some of them were α2A-AR-positive ones. Our electrophysiological recordings also demonstrated that DEX-induced inhibition of Nav1.8 currents was prevented by intracellular application of G-protein inhibitor GDPβ-s or Gi/o proteins inhibitor pertussis toxin (PTX), and bath application of adenylate cyclase (AC) activator forskolin or membrane-permeable cAMP analogue 8-Bromo-cAMP (8-Br-cAMP). PKA inhibitor Rp-cAMP could mimic DEX-induced inhibition of Nav1.8 currents. We established a functional link between α2-AR and Nav1.8 in primary sensory neurons utilizing the Gi/o/AC/cAMP/PKA pathway, which probably mediating peripheral analgesia of DEX.

1 February 2014 in Neuroscience Letters
Verified
Journal Article
Closed access
SLShuang-Shuang Li
Shuang-Shuang Li
WZWei-Shi Zhang
Wei-Shi Zhang
DJDong Ji
Dong Ji
YZYa-Lan Zhou
Ya-Lan Zhou
HLHui Li
Hui Li
HXHua Xu
Hua Xu

1 April 2021 in The Korean Journal of Pain
Verified
Journal Article
Open access
PDF file
CLCaixia Li
Caixia Li
SJSukunya Jirachaipitak
Sukunya Jirachaipitak
PWPaul Wrigley
Paul Wrigley
HXHua Xu
Hua Xu
PEPramote Euasobhon
Pramote Euasobhon
Caixia Li, Sukunya Jirachaipitak, Paul Wrigley, Hua Xu, and Pramote Euasobhon. Korean J Pain 2021;34:156-64. https://doi.org/10.3344/kjp.2021.34.2.156